European Pharma Stocks Rebound from AI Shift
European weight-loss drug makers surge as investors rotate capital from expensive AI stocks into healthcare. Zealand Pharma leads with a 20% weekly jump. Explore the market dynamics.
Category : Search result: European pharma stocks
Purdue Pharma Wins Bankruptcy Approval in Opioid Case
Purdue Pharma receives court approval for $7.4 billion opioid settlement after Supreme Court intervention. Sackler family to pay $6.5 billion over 15 years in landmark case.
Purdue Pharma $7B Opioid Settlement Gets Court Nod
Federal judge approves Purdue Pharma's bankruptcy plan requiring Sackler family to pay $7 billion and surrender company ownership. Thousands of opioid victims to receive compensation in historic settlement.
Lincoln Pharma Aims for Rs 1000 Crore Revenue
Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.
5 Monopoly Stocks for 2026 Watchlist - India Markets
Discover 5 monopoly-style stocks dominating their sectors with strong cash flows and clean balance sheets. These reliable long-term investments offer stability and steady returns for 2026 portfolio planning.
3 Water Infra Stocks to Watch in India
Discover three promising mid-cap and small-cap water infrastructure stocks poised for growth in India's rapidly expanding water management market. Learn about their financial performance and expansion plans.
OneSource Pharma Raises FY28 Revenue Target to $500M
OneSource Pharma hikes FY28 revenue guidance to over $500 million, plans $100M expansion for weight-loss drugs like semaglutide. CEO reveals accelerated growth strategy.
Gujarat Pharma Factory Blast: 2 Dead, 20 Injured
Tragic boiler explosion at pharmaceutical factory in Gujarat's Bharuch district claims 2 lives, leaves 20 injured. Massive fire brought under control by emergency teams.
India's Drug Regulator Tightens Pharma Quality Control
India's DCGI orders nationwide inspections of small pharma units as WHO flags toxic cough syrups. MSMEs struggle to meet new Schedule M compliance deadline of January 2026.
Indian Pharma Units Face Closure Over GMP Non-Compliance
DCGI directs state authorities to enforce strict GMP compliance by December 31, 2025. Delhi, Himachal Pradesh, Uttarakhand already taking action against non-compliant manufacturers.
DCGI Orders Global Pharma Standards Implementation by Jan 2026
India's drug regulator DCGI mandates global manufacturing standards for all pharma companies by January 2026. State regulators ordered to begin inspections immediately. Read about the strict compliance requirements.
Clean Energy Stocks Defy Trump's Climate Denial
Despite Trump's anti-climate rhetoric, renewable energy stocks are showing surprising resilience. Discover why market forces are overpowering political denial in the clean tech revolution.
Thangamayil Jewellery Stock Jumps 70% in 10 Sessions
Discover how Thangamayil Jewellery shares skyrocketed 70% despite market weakness, with strong Q4 results driving investor frenzy. Is this multibagger in your portfolio?
Sun Pharma: US Tariff Clarity & Q2 FY26 Outlook
Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.
European Film Festival in Bengaluru from Nov 7
Bengaluru gears up for the much-awaited European Film Festival featuring 24 award-winning movies from 24 countries at Goethe-Institut. Don't miss this cultural extravaganza!
Indian Pharma Soars with Record US Generic Drug Profits
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Piramal Pharma Bets on US Biopharma Funding Revival
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
8 Hidden European Food Gems You Must Try
Move beyond pizza and pasta! Discover Europe's best-kept culinary secrets - from Portugal's surprising sandwich to Poland's secret soup that will transform your food journey.
Tech Sector Reset: Nvidia Earnings Critical for Recovery
As global tech stocks face a major correction, all eyes turn to Nvidia's upcoming earnings report. Discover how the AI chip giant's performance could determine the sector's future trajectory amid rising Treasury yields and valuation concerns.
8 Hidden European Dishes You Must Try
Explore Europe's best-kept culinary secrets! From Portugal's Francesinha to Poland's Żurek, discover 8 underrated dishes that will transform your food journey.
India Mining Boom: 5 Stocks to Watch
Discover how India's mining sector revival is creating unprecedented opportunities in small-cap stocks. Our expert analysis reveals five hidden gems poised for massive growth as government reforms and infrastructure spending accelerate.
Solara Pharma Q2 Loss: ₹10 Crore Amid Challenges
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
Sun Pharma Q2 Profit Rises 2.5% to ₹3,118 Crore
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
EU Waters Down 2040 Climate Target Before COP30
The European Union has finalized a compromised 2040 climate target, raising concerns among environmentalists as crucial COP30 talks approach. Discover how political pressures are shaping Europe's green transition.
Navin Fluorine Shares Surge 22% in 3 Sessions
Discover why Navin Fluorine International shares skyrocketed 22% in just three trading sessions. Expert analysis reveals the key drivers behind this chemical sector powerhouse's impressive rally and what investors should watch next.
Q2 Results Today: Sun Pharma, Grasim, Britannia Earnings
Market eyes Wednesday's Q2 earnings bonanza as pharma giant Sun Pharma, Grasim Industries, and FMCG major Britannia declare results. Get complete analysis and investor expectations.
3 Hot Stocks: Grasim, Aurobindo Pharma, City Union Bank
Religare Broking's Ajit Mishra reveals 3 promising stocks for short-term gains. Discover technical analysis and price targets for Grasim, Aurobindo Pharma, and City Union Bank in this exclusive market insight.
Multibagger Stock Soars 1,100% in One Year
Discover how Waaree Renewables Technologies delivered staggering 1,100% returns in just 12 months, hitting upper circuits repeatedly. Learn what's driving this solar energy stock's phenomenal performance.
Blue Cloud Softech Jumps 4% on Business Wins
Small-cap IT player Blue Cloud Softech Solutions surges 4% after securing significant new business contracts. Discover why this sub-₹50 stock is catching investor attention with its latest expansion moves.
Page 1 of 4